Inactive Instrument
Pressure BioSciences, Inc. Stock Other OTC
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 143K 127K 120K 109K 204K 13.76M 206K 1.44M 554K 7.03M 538K 527K 22.61M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.25M 19.16M 17.38M 32.58M 2.2B 32.9M 230M 88.59M 1.12B 86.17M 84.3M 3.62B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.59K | |
| +0.15% | +3.20% | +47.09% | +34.27% | 251B | |
| -0.54% | +2.27% | +21.53% | -8.86% | 160B | |
| -0.63% | +2.51% | -6.16% | +41.02% | 147B | |
| -0.52% | -2.32% | -54.78% | -16.89% | 63.93B | |
| +1.44% | -0.79% | +14.11% | +27.14% | 50.05B | |
| -0.10% | +4.65% | +41.44% | +56.53% | 49.4B | |
| -0.05% | +1.79% | -14.59% | -19.95% | 48.94B | |
| +0.07% | +4.12% | +53.15% | +61.65% | 43.52B | |
| +0.04% | +9.92% | +196.07% | +98.14% | 41.06B | |
| Average | -0.05% | +4.25% | +33.10% | +30.34% | 94.9B | |
| Weighted average by Cap. | -0.17% | +4.07% | +27.22% | +25.75% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.53M 1.44M 1.31M 2.46M 166M 2.48M 17.32M 6.68M 84.74M 6.49M 6.35M 273M | 1.98M 1.75M 1.65M 1.5M 2.81M 190M 2.84M 19.81M 7.64M 96.91M 7.43M 7.26M 312M |
| Net income | -16.08M -14.19M -13.42M -12.17M -22.82M -1.54B -23.05M -161M -62.06M -788M -60.37M -59.05M -2.54B | -29.31M -25.87M -24.48M -22.2M -41.62M -2.81B -42.03M -294M -113M -1.44B -110M -108M -4.62B |
| Net Debt | 20.53M 18.11M 17.14M 15.54M 29.14M 1.97B 29.43M 206M 79.24M 1.01B 77.07M 75.4M 3.24B | 22.8M 20.13M 19.04M 17.27M 32.38M 2.19B 32.7M 228M 88.04M 1.12B 85.63M 83.77M 3.6B |
Employees
-
